Bioethics News

Growing Number of US Clinics Marketing Unproven Stem Cell Treatments, Study Finds

July 4, 2016

(ABC News) – Stem cells represent for some the promise of a cure from disease or relief from chronic pain conditions — and businesses have taken notice, opening clinics that market different stem-cell treatments directly to consumers. While the use of unapproved stem-cell therapies is commonly associated with international “stem cell tourism,” a new analysis in the journal Cell Stem Cell indicates that this marketplace may be much larger in the United States than previously thought.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.